170 related articles for article (PubMed ID: 31472739)
1. The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver.
Seraj SM; Ayubcha C; Zadeh MZ; Alavi A; Hunt SJ
PET Clin; 2019 Oct; 14(4):419-425. PubMed ID: 31472739
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response.
Kishore SA; Drabkin MJ; Sofocleous CT
PET Clin; 2019 Oct; 14(4):427-436. PubMed ID: 31472740
[TBL] [Abstract][Full Text] [Related]
3. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
[TBL] [Abstract][Full Text] [Related]
4. Role of Fluorodeoxyglucose-PET in Interventional Radiology.
Zandifar A; Saucedo J; Vossough A; Alavi A; Hunt SJ
PET Clin; 2022 Jul; 17(3):543-553. PubMed ID: 35662495
[TBL] [Abstract][Full Text] [Related]
5. Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches.
Zadeh MZ; Raynor WY; Seraj SM; Ayubcha C; Kothekar E; Werner T; Alavi A
PET Clin; 2019 Jul; 14(3):341-352. PubMed ID: 31084774
[TBL] [Abstract][Full Text] [Related]
6. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
[TBL] [Abstract][Full Text] [Related]
7. Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment.
Finessi M; Bellò M; Giunta FP; Veltri A; Deandreis D
Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):165-184. PubMed ID: 29166753
[TBL] [Abstract][Full Text] [Related]
8. Incidentally detected PET-avid liver adenomatosis: MRI and 18F-FDG PET-CT findings.
Öz A; Koyuncu Sökmen B; İnan N; Balcı NC; Tokat Y
Turk J Gastroenterol; 2018 Sep; 29(5):623-624. PubMed ID: 30260790
[No Abstract] [Full Text] [Related]
9. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
[TBL] [Abstract][Full Text] [Related]
10. PET Assessment of Immune Effects from Interventional Oncology Procedures.
Hunt SJ; Seraj SM; Alavi A
PET Clin; 2019 Oct; 14(4):477-485. PubMed ID: 31472745
[TBL] [Abstract][Full Text] [Related]
11. 90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT.
Osborne DR; Acuff S; Neveu M; Kaman A; Syed M; Fu Y
Clin Nucl Med; 2017 May; 42(5):373-374. PubMed ID: 28240669
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
13. Does dual-time-point
Wu B; Zhao Y; Zhang Y; Tan H; Shi H
Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
15. Oncologic
Montilla-Soler JL; Makanji RJ; Barron BJ
Am J Med; 2018 Apr; 131(4):357-364. PubMed ID: 29274757
[TBL] [Abstract][Full Text] [Related]
16. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
Ziai P; Hayeri MR; Salei A; Salavati A; Houshmand S; Alavi A; Teytelboym OM
Radiographics; 2016; 36(2):481-96. PubMed ID: 26963458
[TBL] [Abstract][Full Text] [Related]
17. Musculoskeletal Pitfalls on Fluorodeoxyglucose F 18 PET-Computed Tomography: Pictorial Review.
Asadoorian M; Matcuk GR; Patel DB; Tomasian A; Wassef HR; White EA
PET Clin; 2018 Oct; 13(4):587-607. PubMed ID: 30219190
[TBL] [Abstract][Full Text] [Related]
18. 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
Li P; Liu Q; Wang X; Huang G; Song S
Med Sci Monit; 2019 Jan; 25():558-564. PubMed ID: 30659557
[TBL] [Abstract][Full Text] [Related]
19. Peliosis Hepatis Simulating Metastatic Liver Disease on FDG PET/CT.
Levin D; Hod N; Anconina R; Ezroh Kazap D; Shaco-Levy R; Lantsberg S
Clin Nucl Med; 2018 Jul; 43(7):e234-e236. PubMed ID: 29659400
[TBL] [Abstract][Full Text] [Related]
20. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O
Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
